<VariationArchive VariationID="500889" VariationName="NM_153240.5(NPHP3):c.634dup (p.Glu212fs)" VariationType="Duplication" Accession="VCV000500889" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-12" DateCreated="2018-12-15" MostRecentSubmission="2023-10-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="492313" VariationID="500889">
      <GeneList>
        <Gene Symbol="NPHP3" FullName="nephrocystin 3" GeneID="27031" HGNC_ID="HGNC:7907" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132680609" stop="132722409" display_start="132680609" display_stop="132722409" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132399452" stop="132441302" display_start="132399452" display_stop="132441302" Strand="-" />
          </Location>
          <OMIM>608002</OMIM>
        </Gene>
        <Gene Symbol="NPHP3-ACAD11" FullName="NPHP3-ACAD11 readthrough (NMD candidate)" GeneID="100532724" HGNC_ID="HGNC:48351" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132558138" stop="132722459" display_start="132558138" display_stop="132722459" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_153240.5(NPHP3):c.634dup (p.Glu212fs)</Name>
      <CanonicalSPDI>NC_000003.12:132719029:CCCC:CCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132719029" stop="132719030" display_start="132719029" display_stop="132719030" variantLength="1" positionVCF="132719029" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132437873" stop="132437874" display_start="132437873" display_stop="132437874" variantLength="1" positionVCF="132437873" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>E212fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.132437877dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.132437877dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.132719033dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.132719033dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008130.2" sequenceAccession="NG_008130" sequenceVersion="2" change="g.8403dup">
            <Expression>NG_008130.2:g.8403dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037804.1" sequenceAccession="NR_037804" sequenceVersion="1" change="n.738dup">
            <Expression>NR_037804.1:n.738dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153240.5" sequenceAccession="NM_153240" sequenceVersion="5" change="c.634dup" MANESelect="true">
            <Expression>NM_153240.5:c.634dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_694972.3" sequenceAccession="NP_694972" sequenceVersion="3" change="p.Glu212fs">
            <Expression>NP_694972.3:p.Glu212fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153240.4" sequenceAccession="NM_153240" sequenceVersion="4" change="c.634dup">
            <Expression>NM_153240.4:c.634dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2622548" DB="ClinGen" />
        <XRef Type="rs" ID="747052534" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_153240.5(NPHP3):c.634dup (p.Glu212fs) AND not provided" Accession="RCV000597690" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.634dup (p.Glu212fs) AND Nephronophthisis" Accession="RCV001854072" Version="2">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.634dup (p.Glu212fs) AND multiple conditions" Accession="RCV002506426" Version="1">
        <ClassifiedConditionList TraitSetID="10177">
          <ClassifiedCondition DB="MedGen" ID="C2673885">NPHP3-related Meckel-like syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858392">Nephronophthisis 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3715199">Renal-hepatic-pancreatic dysplasia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.634dup (p.Glu212fs) AND NPHP3-related disorder" Accession="RCV003336089" Version="1">
        <ClassifiedConditionList TraitSetID="87291">
          <ClassifiedCondition>NPHP3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-16" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-12-15" MostRecentSubmission="2023-10-21">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18371931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=NPHP3</URL>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9804" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">NPHP3-related Meckel-like syndrome</ElementValue>
                <XRef ID="MONDO:0009966" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GOLDSTON SYNDROME</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dandy-Walker cyst with renal-hepatic-pancreatic dysplasia</ElementValue>
                <XRef ID="Dandy-Walker+Cyst+with+Renal-Hepatic-Pancreatic+Dysplasia/2103" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Meckel syndrome type 7</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHP3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MKS7</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4665" />
                <XRef ID="4665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3032" DB="Orphanet" />
              <XRef ID="C2673885" DB="MedGen" />
              <XRef ID="MONDO:0009966" DB="MONDO" />
              <XRef Type="MIM" ID="267010" DB="OMIM" />
            </Trait>
            <Trait ID="3602" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal-hepatic-pancreatic dysplasia 1</ElementValue>
                <XRef ID="MONDO:0008833" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RHPD1</ElementValue>
                <XRef Type="MIM" ID="208540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18431" />
                <XRef ID="18431" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3715199" DB="MedGen" />
              <XRef ID="MONDO:0008833" DB="MONDO" />
              <XRef Type="MIM" ID="208540" DB="OMIM" />
            </Trait>
            <Trait ID="5620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Adolescent nephronophthisis</ElementValue>
                <XRef ID="Adolescent+nephronophthisis/7636" DB="Genetic Alliance" />
                <XRef ID="444749006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 3</ElementValue>
                <XRef ID="72010" DB="GeneTests" />
                <XRef ID="MONDO:0011456" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPH3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NPHP3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18179" />
                <XRef ID="18179" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C1858392" DB="MedGen" />
              <XRef ID="MONDO:0011456" DB="MONDO" />
              <XRef Type="MIM" ID="604387" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="87291" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="68860" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NPHP3-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NPHP3-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NPHP3-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1379430" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="60467_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000707032" DateUpdated="2018-12-15" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL ClinVar v180209 classification definitions</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/kvqgb2ud/egl_clinvar_v180209_classification_definitions.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="CC" referenceAllele="C" start="132437874" stop="132437874" variantLength="1" />
            <GeneLocation>NM_153240.4:Ex3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="747052534" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=NPHP3</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4250120" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="447665|MedGen:C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002230435" DateUpdated="2023-02-07" DateCreated="2022-03-28" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18371931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu212Glyfs*3) in the NPHP3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP3 are known to be pathogenic (PMID: 18371931, 23559409). This variant is present in population databases (rs747052534, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with NPHP3-related conditions. ClinVar contains an entry for this variant (Variation ID: 500889). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.132437873_132437874insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5466870" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_153240.5:c.634dup|OMIM:208540;267010;604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002815343" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.634dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="208540" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="267010" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569834" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_153240.4:c.634dup|NPHP3-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046109" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 3 of 27 is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has not been previously reported or functionally characterized in the literature to our knowledge. Loss-of-function variants have been reported in individuals with NPHP3-related disorders (PMID: 32596782). The c.634dup (p.Glu212GlyfsTer3) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.001% (2/251454) and thus is presumed to be rare. Based on the available evidence, the c.634dup (p.Glu212GlyfsTer3) variant is classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.634dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NPHP3-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5466870" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4250120" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5466870" TraitType="Disease" MappingType="XRef" MappingValue="267010" MappingRef="OMIM">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5466870" TraitType="Disease" MappingType="XRef" MappingValue="208540" MappingRef="OMIM">
        <MedGen CUI="C3715199" Name="Renal-hepatic-pancreatic dysplasia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569834" TraitType="Disease" MappingType="Name" MappingValue="NPHP3-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="NPHP3-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1379430" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

